Loading...
XSHE
002755
Market cap2.24bUSD
Dec 05, Last price  
17.08CNY
1D
0.29%
1Q
-25.71%
Jan 2017
-24.39%
IPO
157.74%
Name

Beijing Aosaikang Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHE:002755 chart
P/E
98.90
P/S
8.92
EPS
0.17
Div Yield, %
Shrs. gr., 5y
0.32%
Rev. gr., 5y
-17.02%
Revenues
1.78b
+23.15%
529,171,408494,258,426500,424,755470,869,196278,157,189178,357,925365,933,9303,931,881,7264,518,631,6923,782,688,9123,106,666,5691,872,572,1891,443,459,6081,777,641,912
Net income
160m
P
49,135,19159,954,11255,521,02537,504,22718,864,5364,604,64610,966,920670,073,623780,959,203721,625,102379,907,7870-148,529,759160,294,273
CFO
411m
P
0106,470,20200016,729,5320497,158,803534,615,973580,383,967567,707,6500-26,568,451411,357,064
Dividend
Jun 20, 20220.1 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in digestive, oncology, antibiotic, and other areas. Beijing Aosaikang Pharmaceutical Co., Ltd. was founded in 2003 and is based in Nanjing, China.
IPO date
May 15, 2015
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT